Overview

Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Proof of concept study in islet transplantation, two treatment arms (ATG SIR-TAC versus ATG SIR) each consisting of ten type 1 diabetic patients
Phase:
N/A
Details
Lead Sponsor:
AZ-VUB
Collaborators:
Belgian Government
Fund for Scientific Research, Flanders, Belgium
Treatments:
Everolimus
Sirolimus
Tacrolimus